About This Page
This is a clinician-written, evidence-based summary aligned to the USMLE Step 2 CK Content Outline. It is intended for medical students preparing for USMLE Step 2 CK. Management reflects current ACC/AHA, USPSTF, and APA guidelines. Always cross-reference with UpToDate, institutional protocols, and clinical judgment.
The Bottom Line
- Pleural Effusion is a high-yield USMLE Step 2 CK respiratory topic requiring diagnosis plus next-best-step management
- Severity assessment comes first: unstable patients need immediate stabilization before definitive diagnostic workup
- Use US guideline pathways, imaging, physiology, microbiology, pathology, or risk scoring depending on the condition
- Management depends on cause, severity, comorbidities, and risk of complications
- Exam stems often hinge on classic clues, contraindications, and when to escalate to imaging, procedure, or ICU care
Overview
Pleural effusion results from imbalance between pleural fluid formation and absorption. Transudates arise from systemic pressure abnormalities such as heart failure, cirrhosis, and nephrotic syndrome. Exudates arise from local pleural inflammation or impaired lymphatic drainage, including pneumonia, malignancy, pulmonary embolism, tuberculosis, and autoimmune disease.
Epidemiology
Heart failure is the most common cause of bilateral transudative effusions in US practice. Pneumonia, malignancy, and pulmonary embolism are common causes of exudative effusions. Lung cancer and breast cancer are frequent causes of malignant pleural effusion, which usually indicates advanced disease.
Clinical Features
Symptoms
Dyspnea, often proportional to size and rate of fluid accumulation
Pleuritic chest pain, especially with inflammation or pulmonary embolism
Cough or reduced exercise tolerance
Fever and productive cough suggesting parapneumonic effusion
Weight loss, night sweats, or recurrent effusion suggesting malignancy or tuberculosis
Signs
Decreased breath sounds over effusion
Dullness to percussion and reduced tactile fremitus
Tracheal deviation away from very large effusion
Pleural friction rub if associated pleuritis
Peripheral edema, elevated JVP, or ascites suggesting systemic transudative cause
Investigations
First-line
Chest X-rayBlunting of costophrenic angle, meniscus sign, layering on decubitus film; large effusion can opacify hemithorax
Thoracic ultrasoundConfirms fluid, estimates size, identifies septations, and guides safe thoracentesis
Diagnostic thoracentesisIndicated for most new unilateral effusions, large unexplained effusions, suspected infection, malignancy, or atypical heart failure features
Second-line
Pleural fluid analysisCell count, protein, LDH, glucose, pH, Gram stain/culture, cytology; add AFB, ADA, triglycerides, amylase, or autoimmune tests when indicated
Light criteriaExudate if pleural/serum protein >0.5, pleural/serum LDH >0.6, or pleural LDH >2/3 upper limit of normal serum LDH
CT chest with contrastEvaluate malignancy, pulmonary embolism, loculations, pleural thickening, or lung abscess
Specialist
Pleural biopsy or thoracoscopyFor suspected malignancy or tuberculosis when cytology and fluid studies are nondiagnostic
BronchoscopyIf endobronchial obstruction or post-obstructive process is suspected
Management
ATS/STS/STR 2018 Malignant Pleural Effusion Guideline and AATS Empyema Consensus Guideline1
General approach
- Treat underlying cause: diuresis for heart failure, antibiotics for pneumonia, anticoagulation for PE, oncologic therapy for malignancy
- Therapeutic thoracentesis for symptomatic large effusion
- Use ultrasound guidance for thoracentesis to reduce pneumothorax risk
2
Parapneumonic effusion and empyema
- Drain if frank pus, positive Gram stain/culture, pleural pH <7.20, low glucose, loculated effusion, or large effusion
- Chest tube drainage plus antibiotics is standard for empyema
- Consider intrapleural fibrinolytic/DNase or VATS for loculated empyema or inadequate drainage
3
Malignant pleural effusion
- Initial large-volume thoracentesis assesses symptom response and lung re-expansion
- Recurrent symptomatic effusion with expandable lung: indwelling pleural catheter or chemical pleurodesis
- Trapped lung: indwelling pleural catheter is generally preferred
Complications
- Respiratory failure: Severe disease can progress to hypoxemia, hypercapnia, or need for ventilatory support
- Secondary infection: Damaged or obstructed lung is prone to bacterial infection
- Pulmonary hypertension: Chronic hypoxemia or parenchymal disease can increase pulmonary vascular resistance
- Delayed diagnosis: Incidental or nonspecific presentations may hide malignancy, TB, PE, or ILD
- Treatment toxicity: Antimicrobials, corticosteroids, anticoagulants, chemotherapy, or procedures can cause harm
USMLE Step 2 CK Exam Tips
- 1Light criteria: any one positive criterion makes an effusion exudative
- 2Low pleural pH (<7.20) in parapneumonic effusion = chest tube drainage
- 3Heart failure causes bilateral transudative effusions; treat classic bilateral HF effusions with diuresis first
- 4Unilateral new effusion generally needs diagnostic thoracentesis
- 5Malignant pleural effusion is exudative and cytology may reveal adenocarcinoma cells
- 6Milky pleural fluid with high triglycerides = chylothorax
- 7Pleural fluid amylase elevation suggests pancreatitis or esophageal rupture
practicetest your knowledge on pleural effusionApply what you've learnt with USMLE Step 2 CK-style questions from the iatroX Q-Bank — respiratory and beyond.
open q-bank